ATLASATLAS fair value
ATLAS has no fair value for this stock today.
60 Degrees Pharmaceuticals (SXTP)
60 Degrees Pharmaceuticals stock price today, ATLAS forecast and fair value
Healthcare · Biotechnology · NASDAQ
$0.66▼ -23.76%
Prices as of Oct 26, 2026 · USD
Chance of rising in 1 month
44%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on 60 Degrees Pharmaceuticals in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On 60 Degrees Pharmaceuticals
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives 60 Degrees Pharmaceuticals a 44% chance of finishing higher a month from now (21 trading sessions) than today: somewhat worse than a coin flip.
In half of the simulated outcomes the price ends between $0.53 and $0.76; in 9 out of 10, between $0.39 and $1.04. Estimated annual volatility is 104%.
Price, last 12 months (weekly close)
Key numbers
- 52-week high
- $5.68
- 52-week low
- $0.66
- Revenue (12 months)
- $1.2M
- Revenue growth (YoY)
- +65.5%
- Gross margin
- 22.3%
- Return on equity
- -332.9%
- Free cash flow (12 months)
- $-6.1M
- Beta
- 2.54
What this means
ATLAS does not publish a fair value for SXTP right now, but it does show its odds of rising: somewhat worse than a coin flip.
Over the last 52 weeks SXTP has traded between $0.66 and $5.68. Today it is 88.4% below that high and 0% above its low.
Its beta is 2.54: it tends to move more than the market, both up and down.
About the company
60 Degrees Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing medicines for the prevention and treatment of infectious diseases.
Want to see everything about 60 Degrees Pharmaceuticals?
Get started →Plans from €3.99 a month.
Frequently asked questions
What does 60 Degrees Pharmaceuticals do?
60 Degrees Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing medicines for the prevention and treatment of infectious diseases.
What is the chance SXTP goes up next month?
44%: somewhat worse than a coin flip. In half of the simulated outcomes, SXTP ends the month between $0.53 and $0.76.
How volatile is SXTP?
ATLAS estimates annual volatility at 104%. In a typical month, half of the outcomes end between $0.53 and $0.76.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer